Zota Health Care invested ₹20.20 Crore in its subsidiary, Davaindia Health Mart, via a rights issue. This capital supports strategic store expansion and working capital needs.
Zota Health Care confirmed zero deviation in utilizing ₹722.50 Crore raised via preferential issues and QIP. Funds were fully deployed toward stated corporate and expansion objects.
Zota Health Care Limited confirmed full utilization of its ₹179.07 Crore preferential issue proceeds. CRISIL Ratings' report indicates zero unutilized funds as of March 31, 2026.
